Developer docs
API playgroundTry for free, no card

Search company profiles

Global Alliance for Regenerative Medicine

Full company profile

uuid00pp45o

Namestring
Global Alliance for Regenerative Medicine
Legal namestring
Global Alliance for Regenerative Medicine
Websiteurl
garmclinic.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Global Alliance for Regenerative Medicine (GARM Clinic) is a privately held, founder-led regenerative medicine operator founded in 2014 by Dr. Glenn C. Terry, a US board-certified orthopedic surgeon formerly of the Hughston Clinic and US Olympic Team physician. GARM delivers autologous and donor-derived stem cell therapies, gene therapies (Follistatin and VEGF plasmids), exosome therapy, PRP, advanced IV drips, and proprietary protocols (DiscShield, Brain RESET, Biological Reset, Klotho via lipid nanoparticle) through two clinical sites: the flagship in Parrot Tree, Roatán, Honduras — operating within the Próspera autonomous special economic zone — and a second facility opened in 2024 on Paradise Island, Bahamas, under the Bahamas' Longevity and Regenerative Therapies Act. Both jurisdictions permit regenerative and gene therapies not yet approved by the US FDA, which is the structural basis of GARM's market position.

The company runs a direct-to-consumer medical-tourism model targeting affluent international patients (primarily from the US, Canada, and Europe) seeking non-surgical orthopedic care, chronic disease interventions (arthritis, autoimmune conditions, COPD, type 2 diabetes), elite-athlete recovery, and longevity optimization. Patients receive individually customized, physician-led protocols priced per treatment on a fee-for-service basis, with concierge support for travel, lodging, and telemedicine follow-up; a subscription-based Longevity Program is also offered. Revenue streams include treatment fees, CRO-style clinical trial hosting (notably Klothea Bio's Phase 1b AKL003 alpha-Klotho mRNA trial), partner-product distribution (Nymox's Nymozarfex), and resort-based IV/aesthetic services delivered through a Kimpton Grand Roatan spa partnership.

GARM markets through high-leverage channels — a Netflix documentary feature, Joe Rogan podcast exposure, Kevin Harrington (original Shark Tank) partnership, Departures Magazine coverage, and XPRIZE Healthspan semifinalist status for the Brain RESET Protocol. The clinic has 1–10 employees, no disclosed outside funding, and is bootstrapped under founder and CEO Heather Terry's executive leadership. Recent strategic activity (2024–2026) — Bahamas launch, Klotho residency program, clinical trial hosting, new drug distribution, and resort partnership — indicates a transition from a single-clinic concierge practice toward a multi-jurisdiction regenerative-medicine platform with CRO and recurring-revenue components.

Short descriptiontext

GARM Clinic is a privately held, founder-led regenerative medicine operator in Roatán, Honduras and Paradise Island, Bahamas that delivers autologous stem cell therapies, gene therapies, exosomes, and longevity protocols to affluent international medical tourists seeking treatments not yet approved by the US FDA.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersRoatán, Honduras
HQ citystring
Roatán
HQ countrystring
Honduras
HQ regionstring
Latin America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
regenerative medicine treatments, stem cell therapy, gene therapy, medical tourism, longevity programs
Industry6 codes
1Cell Therapy Developers (Autologous)
CodeHLAAABAAPrimaryYes
2Stem Cell Therapies (MSC/iPSC/HSC-derived)
CodeHLAAABAEPrimaryNo
3Stem Cell–Based Regenerative Therapies
CodeHLAAAGAAPrimaryNo
4Cell Therapy Clinical Services & Treatment Centers (apheresis, administration, monitoring)
CodeHLAAABAJPrimaryNo
5Gene Therapy Delivery Devices & Administration Systems (catheters, intrathecal, ocular delivery)
CodeHLAAACALPrimaryNo
6Nephrology & Urology Specialty Pharmaceuticals
CodeHLAIACAHPrimaryNo
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code3 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Commercial Physical & Biological Research8731
  • Services-Health Services8000
Product category
Regenerative Medicine
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Regenerative Medicine Treatments
TypeOne Time License
Description

Fee-for-service medical treatments including stem cell therapies, gene therapies, exosome treatments, and PRP. Customized treatment protocols priced individually based on patient needs and treatment complexity.

garmclinic.com
2Clinical Trial Hosting (CRO)
TypeProfessional Services
Description

Contract Research Organization model hosting clinical trials for regenerative medicine companies. Manages portfolio of therapies undergoing clinical testing.

garmclinic.com
3Longevity Programs
TypeSubscription Recurring
Description

Comprehensive multi-modal longevity packages combining diagnostics, gene therapies, stem cell treatments, and ongoing wellness protocols.

garmclinic.com
4Spa Partnership Treatments
TypeOne Time License
Description

Regenerative therapies and aesthetic treatments offered through Kimpton Grand Roatan's Kao Kamasa Spa partnership including IV therapies, longevity drips, and regenerative aesthetics.

garmclinic.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details1 tier
1Customized autologous stem cell treatments - individually priced based on patient needs
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Each patient receives a detailed, customized treatment plan developed after comprehensive evaluation. Prices vary based on treatment complexity, number of conditions addressed, and specific procedures required.

garmclinic.com
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 2 records shown
1GARM Clinic
Description

Primary medical facility brand offering regenerative medicine, stem cell therapies, gene therapies, and longevity programs in Roatán and Bahamas locations.

garmclinic.com
+1 more record
Core offering1 text field

GARM Clinic operates a regenerative medicine medical tourism platform delivering stem cell therapies (autologous, allogeneic, cultured, and MUSE-derived), gene therapies (Follistatin and VEGF plasmid), exosome therapies, PRP, and longevity protocols to affluent international patients. Treatments are physician-led, customized per patient after comprehensive diagnostics, and delivered at facilities in Roatán, Honduras and Paradise Island, Bahamas under regulatory frameworks that allow therapies not yet FDA-approved in the US.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 50-90% reduction in outbreak frequency for HSV patients over 13 years of clinical experience
+3 more records
Product overview1 text field

GARM Clinic operates as a multi-service regenerative medicine platform offering a comprehensive portfolio of cellular, gene, and biologic therapies organized around four core pillars: Stem Cell Therapy (autologous, allogeneic, cultured, and MUSE-derived), Gene Therapy (Follistatin and VEGF plasmid), Advanced IV Therapies (longevity, restorative, and performance drips), and Longevity Medicine (Brain RESET Protocol, Biological Reset Protocol, Klotho therapy). The platform also includes specialized programs for Orthopedic/Athlete Care, Regenerative Aesthetics, Wellness Optimization, and specific treatments for HSV, diabetes, COPD, erectile dysfunction, and prostate conditions. The flagship location is on Roatán Island, Honduras, with a newer facility on Paradise Island, Bahamas, both operating under a physician-led, personalized protocol model where treatments are customized per patient after comprehensive diagnostics. GARM serves medical tourists seeking alternatives to conventional medicine and surgery.

Product and service17 records
1Stem Cell Therapy
CategoryRegenerative Medicine
Description

Stem cell treatments using autologous, allogeneic, cultured, and MUSE-derived stem cells for orthopedic, autoimmune, longevity, and wellness applications. Targeted at patients seeking non-surgical regenerative solutions.

2Follistatin Plasmid Gene Therapy
CategoryGene Therapy
Description

Gene therapy that reverses epigenetic aging by up to 12 years, inhibits myostatin to increase lean muscle mass, preserve muscle, increase bone density, and reduce body fat.

3VEGF Plasmid Gene Therapy
CategoryGene Therapy
Description

Vascular endothelial growth factor gene therapy increasing vascularization and oxygenation to tissues, used for critical limb ischemia and studied for improving endurance and recovery.

4PRP (Platelet-Rich Plasma) Therapy
CategoryRegenerative Medicine
Description

Concentrated platelet injections derived from patient's own blood to accelerate healing and regeneration of tissues.

5Exosome Therapy
CategoryRegenerative Medicine
Description

Biologic-derived signaling molecules that support cellular communication, rejuvenation, and whole-body vitality through placenta-derived exosomes.

6Longevity Program
CategoryLongevity Medicine
Description

Comprehensive multi-modal program including joint preservation, gene therapies, exosomes, IV stem cells, MUSE cells, and Brain RESET Protocol targeting biological mechanisms of aging.

7Brain RESET Protocol
CategoryLongevity Medicine
Description

XPRIZE finalist research protocol combining IV exosomes and targeted Low-Intensity Focused Ultrasound (LIFU) to improve memory, reduce cortisol, enhance deep sleep, and alleviate anxiety.

8DiscShield
CategoryOrthopedic Regenerative Therapy
Description

Proprietary non-surgical, image-guided treatment for herniated or leaky discs, degenerative disc disease, and chronic back or neck pain to stabilize and restore spinal disc function.

9Biological Reset Protocol
CategoryLongevity Medicine
Description

Comprehensive multi-day regimen combining plasmapheresis, targeted IV therapy (NAD+, amino acids, antioxidants), and neurological enhancers for improved sleep, recovery, and cognitive clarity.

10Klotho Longevity Therapy
CategoryLongevity Medicine
Description

Proprietary intravenous Klotho therapy delivered via lipid nanoparticle platform with pre- and post-procedure serum biomarker monitoring for longevity and anti-aging purposes.

11HSV Immunotherapy Protocol
CategorySpecialty Therapy
Description

Three-phase immunotherapy protocol for recurrent herpes simplex virus (HSV-1 and HSV-2) that retrains the immune system for sustained viral suppression, demonstrating 50-90% reduction in outbreak frequency.

12Advanced IV Therapies
CategoryIV Therapy
Description

Curated IV therapies including longevity drips (NAD+), restorative drips, performance drips, and regenerative biologic support infusions for energy, recovery, and performance.

13Regenerative Aesthetic Treatments
CategoryAesthetic Regenerative Medicine
Description

Cellular rejuvenation and precision aesthetics using advanced biologics and growth factors to restore skin health, tone, and texture, including non-surgical facelifts with unfocused acoustic wave technology.

14Erectile Dysfunction Treatment
CategorySpecialty Therapy
Description

Treatment combining pulsed energy waves with targeted injections of stem cells, optionally optimized with exosome IV.

15Metabolic Optimization and Plasmapheresis
CategoryLongevity Medicine
Description

Detoxification and oxidative stress reduction protocols using glutathione and essential B vitamins to boost energy, strengthen immunity, and promote cellular health.

16Klotho Longevity Residency
CategoryLongevity Program
Description

Multi-day residency event at Kimpton Grand Roatán Resort featuring Klotho researchers, proprietary intravenous Klotho therapy via lipid nanoparticle platform, and pre/post biomarker monitoring.

17Clinical Trial Hosting (CRO Services)
CategoryClinical Research Services
Description

Contract Research Organization model hosting clinical trials for regenerative medicine companies, managing portfolio of therapies undergoing clinical testing in regulatory-favorable jurisdictions.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-06-17
Description

Formal agreement to offer Nymozarfex(TM) drug treatment for prostate conditions at GARM facility on Roatan Island. Marks drug's first public availability, with certified urologists providing treatment for medical tourists. Positioned as safer alternative to existing drugs and surgical options with fewer side effects and no anesthesia requirement.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-02-24
Description

Phase 1b clinical trial hosting for AKL003, Klothea Bio's alpha Klotho mRNA therapeutic designed to extend human lifespan. Randomized, double-blind, placebo-controlled study enrolling 21 healthy adults (ages 25-75). Trial conducted at GARM Clinic in Próspera, Roatan within autonomous special economic zone regulatory framework.

Strategic tierMajorTypeGTM or Marketing PartnerAnnounced on2023-07-20
Description

Strategic partnership with original Shark Tank investor and entrepreneur Kevin Harrington. Collaboration featured in Harrington's 'American Entrepreneur' venture, marking a significant milestone in regenerative medicine marketing. Aims to provide patients with unparalleled access to cutting-edge information and empower informed health decisions.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2016-06-15
Description

Alliance member partnership with Hospital Cemesa Roatan, opened June 2016. Modern facility with 24-hour emergency services, diagnostic laboratory, 4 operating rooms under JCAHO standards, MRI and angiogram capabilities. Supports expansion of regenerative medicine field with state-of-the-art medical infrastructure.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration bringing regenerative IV therapies and aesthetic treatments to resort guests. GARM provides professionally trained medical team inside spa environment while Kimpton curates guest experience. Treatments include IV therapies, longevity drips, restorative drips, performance drips, stem cell & exosome drips, and regenerative aesthetic treatments.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Stem cell therapy clinic in Medellín, Colombia offering autologous and allogeneic treatments for orthopedic, autoimmune, and chronic conditions to international patients. Directly competes with GARM in the medical tourism regenerative medicine space.

TypeBroad incumbent
Description

Large medical device company focused on spine and orthopedic surgical solutions. Represents the conventional surgical alternative that GARM positions its regenerative treatments against.

TypeDirect peer
Description

Former Freeport, Bahamas-based regenerative medicine clinic using adult stem cell therapy under Bahamian regulatory framework. Direct geographic and regulatory peer to GARM's Bahamas location.

TypeDirect peer
Description

US network of interventional orthopedics clinics offering image-guided bone marrow concentrate injections and regenerative therapies. Comparable orthopedic regenerative medicine focus with broader US footprint.

TypeDirect peer
Description

Frankfurt, Germany and US-based regenerative medicine clinic combining stem cell therapy, IV protocols, and longevity treatments. Comparable multi-modal longevity offering to GARM's Biological Reset and Klotho programs.

TypeDirect peer
Description

California-based stem cell therapy clinic offering autologous adipose-derived stem cell treatments for orthopedic and degenerative conditions. Closest US-domestic comparator with similar cell processing approach.

TypeDirect peer
Description

Miami-based regenerative medicine and hormone therapy clinic offering stem cell, PRP, and IV treatments to affluent domestic clientele. Comparable boutique regenerative medicine positioning in the US market.

TypeOthers
Description

Alpha Klotho mRNA therapeutic developer currently running Phase 1b trial at GARM Clinic. Partner rather than competitor, but illustrative of biotech clients GARM could serve through its CRO platform.

TypeDirect peer
Description

Autologous mesenchymal stem cell therapy provider operating in Cancun, Mexico, targeting US medical tourists with similar FDA-arbitrage model. Closest structural competitor to GARM in the regenerative medical tourism category.

TypeDirect peer
Description

Regenerative medicine clinic in Switzerland and Serbia offering stem cell therapy and anti-aging protocols to international patients. Comparable premium medical tourism positioning with longevity focus.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Global Alliance for Regenerative Medicine

Regenerative Medicinegarmclinic.com

GARM Clinic is a privately held, founder-led regenerative medicine operator in Roatán, Honduras and Paradise Island, Bahamas that delivers autologous stem cell therapies, gene therapies, exosomes, and longevity protocols to affluent international medical tourists seeking treatments not yet approved by the US FDA.

What Global Alliance for Regenerative Medicine does

Global Alliance for Regenerative Medicine (GARM Clinic) is a privately held, founder-led regenerative medicine operator founded in 2014 by Dr. Glenn C. Terry, a US board-certified orthopedic surgeon formerly of the Hughston Clinic and US Olympic Team physician. GARM delivers autologous and donor-derived stem cell therapies, gene therapies (Follistatin and VEGF plasmids), exosome therapy, PRP, advanced IV drips, and proprietary protocols (DiscShield, Brain RESET, Biological Reset, Klotho via lipid nanoparticle) through two clinical sites: the flagship in Parrot Tree, Roatán, Honduras — operating within the Próspera autonomous special economic zone — and a second facility opened in 2024 on Paradise Island, Bahamas, under the Bahamas' Longevity and Regenerative Therapies Act. Both jurisdictions permit regenerative and gene therapies not yet approved by the US FDA, which is the structural basis of GARM's market position.

The company runs a direct-to-consumer medical-tourism model targeting affluent international patients (primarily from the US, Canada, and Europe) seeking non-surgical orthopedic care, chronic disease interventions (arthritis, autoimmune conditions, COPD, type 2 diabetes), elite-athlete recovery, and longevity optimization. Patients receive individually customized, physician-led protocols priced per treatment on a fee-for-service basis, with concierge support for travel, lodging, and telemedicine follow-up; a subscription-based Longevity Program is also offered. Revenue streams include treatment fees, CRO-style clinical trial hosting (notably Klothea Bio's Phase 1b AKL003 alpha-Klotho mRNA trial), partner-product distribution (Nymox's Nymozarfex), and resort-based IV/aesthetic services delivered through a Kimpton Grand Roatan spa partnership.

GARM markets through high-leverage channels — a Netflix documentary feature, Joe Rogan podcast exposure, Kevin Harrington (original Shark Tank) partnership, Departures Magazine coverage, and XPRIZE Healthspan semifinalist status for the Brain RESET Protocol. The clinic has 1–10 employees, no disclosed outside funding, and is bootstrapped under founder and CEO Heather Terry's executive leadership. Recent strategic activity (2024–2026) — Bahamas launch, Klotho residency program, clinical trial hosting, new drug distribution, and resort partnership — indicates a transition from a single-clinic concierge practice toward a multi-jurisdiction regenerative-medicine platform with CRO and recurring-revenue components.

Global Alliance for Regenerative Medicine firmographics

Firmographics
Name
Global Alliance for Regenerative Medicine
Legal name
Global Alliance for Regenerative Medicine
Website
https://garmclinic.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
1–10 employees
Short description
GARM Clinic is a privately held, founder-led regenerative medicine operator in Roatán, Honduras and Paradise Island, Bahamas that delivers autologous stem cell therapies, gene therapies, exosomes, and longevity protocols to affluent international medical tourists seeking treatments not yet approved by the US FDA.
Ownership category
akta.pro rank

Global Alliance for Regenerative Medicine industry classification

Industry
Product category
Regenerative Medicine
NAICS
Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)
akta.pro primary industry
Cell Therapy Developers (Autologous) (HLAAABAA)
akta.pro secondary industries
Stem Cell Therapies (MSC/iPSC/HSC-derived) (HLAAABAE), Stem Cell–Based Regenerative Therapies (HLAAAGAA), Cell Therapy Clinical Services & Treatment Centers (apheresis, administration, monitoring) (HLAAABAJ), Gene Therapy Delivery Devices & Administration Systems (catheters, intrathecal, ocular delivery) (HLAAACAL), Nephrology & Urology Specialty Pharmaceuticals (HLAIACAH)

Keywords

  • Regenerative medicine treatments
  • Stem cell therapy
  • Gene therapy
  • Medical tourism
  • Longevity programs

Where Global Alliance for Regenerative Medicine is headquartered

Location

Headquarters

HQ city
Roatán
HQ country
Honduras
HQ region
Latin America

Offices3 records

Markets served

Global Alliance for Regenerative Medicine business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Regenerative Medicine Treatments: Fee-for-service medical treatments including stem cell therapies, gene therapies, exosome treatments, and PRP. Customized treatment protocols priced individually based on patient needs and treatment complexity.
  2. Clinical Trial Hosting (CRO): Contract Research Organization model hosting clinical trials for regenerative medicine companies. Manages portfolio of therapies undergoing clinical testing.
  3. Longevity Programs: Comprehensive multi-modal longevity packages combining diagnostics, gene therapies, stem cell treatments, and ongoing wellness protocols.
  4. Spa Partnership Treatments: Regenerative therapies and aesthetic treatments offered through Kimpton Grand Roatan's Kao Kamasa Spa partnership including IV therapies, longevity drips, and regenerative aesthetics.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goCustomized autologous stem cell treatments - individually priced based on patient needs

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Global Alliance for Regenerative Medicine product offering

Product offering

Core offering

GARM Clinic operates a regenerative medicine medical tourism platform delivering stem cell therapies (autologous, allogeneic, cultured, and MUSE-derived), gene therapies (Follistatin and VEGF plasmid), exosome therapies, PRP, and longevity protocols to affluent international patients. Treatments are physician-led, customized per patient after comprehensive diagnostics, and delivered at facilities in Roatán, Honduras and Paradise Island, Bahamas under regulatory frameworks that allow therapies not yet FDA-approved in the US.

Product overview

GARM Clinic operates as a multi-service regenerative medicine platform offering a comprehensive portfolio of cellular, gene, and biologic therapies organized around four core pillars: Stem Cell Therapy (autologous, allogeneic, cultured, and MUSE-derived), Gene Therapy (Follistatin and VEGF plasmid), Advanced IV Therapies (longevity, restorative, and performance drips), and Longevity Medicine (Brain RESET Protocol, Biological Reset Protocol, Klotho therapy). The platform also includes specialized programs for Orthopedic/Athlete Care, Regenerative Aesthetics, Wellness Optimization, and specific treatments for HSV, diabetes, COPD, erectile dysfunction, and prostate conditions. The flagship location is on Roatán Island, Honduras, with a newer facility on Paradise Island, Bahamas, both operating under a physician-led, personalized protocol model where treatments are customized per patient after comprehensive diagnostics. GARM serves medical tourists seeking alternatives to conventional medicine and surgery.

Differentiator

Problem solved

Functional benefit

Brands

  • GARM Clinic: Primary medical facility brand offering regenerative medicine, stem cell therapies, gene therapies, and longevity programs in Roatán and Bahamas locations.
  • GARM × Kimpton Grand Roatán Resort and Spa Partnership

Products and services

  • Stem Cell Therapy Stem cell treatments using autologous, allogeneic, cultured, and MUSE-derived stem cells for orthopedic, autoimmune, longevity, and wellness applications. Targeted at patients seeking non-surgical regenerative solutions.
  • Follistatin Plasmid Gene Therapy Gene therapy that reverses epigenetic aging by up to 12 years, inhibits myostatin to increase lean muscle mass, preserve muscle, increase bone density, and reduce body fat.
  • VEGF Plasmid Gene Therapy Vascular endothelial growth factor gene therapy increasing vascularization and oxygenation to tissues, used for critical limb ischemia and studied for improving endurance and recovery.
  • PRP (Platelet-Rich Plasma) Therapy Concentrated platelet injections derived from patient's own blood to accelerate healing and regeneration of tissues.
  • Exosome Therapy Biologic-derived signaling molecules that support cellular communication, rejuvenation, and whole-body vitality through placenta-derived exosomes.
  • Longevity Program Comprehensive multi-modal program including joint preservation, gene therapies, exosomes, IV stem cells, MUSE cells, and Brain RESET Protocol targeting biological mechanisms of aging.
  • Brain RESET Protocol XPRIZE finalist research protocol combining IV exosomes and targeted Low-Intensity Focused Ultrasound (LIFU) to improve memory, reduce cortisol, enhance deep sleep, and alleviate anxiety.
  • DiscShield Proprietary non-surgical, image-guided treatment for herniated or leaky discs, degenerative disc disease, and chronic back or neck pain to stabilize and restore spinal disc function.
  • Biological Reset Protocol Comprehensive multi-day regimen combining plasmapheresis, targeted IV therapy (NAD+, amino acids, antioxidants), and neurological enhancers for improved sleep, recovery, and cognitive clarity.
  • Klotho Longevity Therapy Proprietary intravenous Klotho therapy delivered via lipid nanoparticle platform with pre- and post-procedure serum biomarker monitoring for longevity and anti-aging purposes.
  • HSV Immunotherapy Protocol Three-phase immunotherapy protocol for recurrent herpes simplex virus (HSV-1 and HSV-2) that retrains the immune system for sustained viral suppression, demonstrating 50-90% reduction in outbreak frequency.
  • Advanced IV Therapies Curated IV therapies including longevity drips (NAD+), restorative drips, performance drips, and regenerative biologic support infusions for energy, recovery, and performance.
  • Regenerative Aesthetic Treatments Cellular rejuvenation and precision aesthetics using advanced biologics and growth factors to restore skin health, tone, and texture, including non-surgical facelifts with unfocused acoustic wave technology.
  • Erectile Dysfunction Treatment Treatment combining pulsed energy waves with targeted injections of stem cells, optionally optimized with exosome IV.
  • Metabolic Optimization and Plasmapheresis Detoxification and oxidative stress reduction protocols using glutathione and essential B vitamins to boost energy, strengthen immunity, and promote cellular health.
  • Klotho Longevity Residency Multi-day residency event at Kimpton Grand Roatán Resort featuring Klotho researchers, proprietary intravenous Klotho therapy via lipid nanoparticle platform, and pre/post biomarker monitoring.
  • Clinical Trial Hosting (CRO Services) Contract Research Organization model hosting clinical trials for regenerative medicine companies, managing portfolio of therapies undergoing clinical testing in regulatory-favorable jurisdictions.

Quantifiable outcome

  • 50-90% reduction in outbreak frequency for HSV patients over 13 years of clinical experience
  • +3 more outcomes

Companies that use Global Alliance for Regenerative Medicine

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles5 records

Global Alliance for Regenerative Medicine technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

Global Alliance for Regenerative Medicine partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered major, minor and core.

  • Nymox Pharmaceutical CorporationmajorStrategic or Co-development Partner · 17 June 2026Formal agreement to offer Nymozarfex(TM) drug treatment for prostate conditions at GARM facility on Roatan Island. Marks drug's first public availability, with certified urologists providing treatment for medical tourists. Positioned as safer alternative to existing drugs and surgical options with fewer side effects and no anesthesia requirement.
  • Klothea BiomajorStrategic or Co-development Partner · 24 February 2026Phase 1b clinical trial hosting for AKL003, Klothea Bio's alpha Klotho mRNA therapeutic designed to extend human lifespan. Randomized, double-blind, placebo-controlled study enrolling 21 healthy adults (ages 25-75). Trial conducted at GARM Clinic in Próspera, Roatan within autonomous special economic zone regulatory framework.
  • Kevin HarringtonmajorGTM or Marketing Partner · 20 July 2023Strategic partnership with original Shark Tank investor and entrepreneur Kevin Harrington. Collaboration featured in Harrington's 'American Entrepreneur' venture, marking a significant milestone in regenerative medicine marketing. Aims to provide patients with unparalleled access to cutting-edge information and empower informed health decisions.
  • Hospital Cemesa RoatanminorStrategic or Co-development Partner · 15 June 2016Alliance member partnership with Hospital Cemesa Roatan, opened June 2016. Modern facility with 24-hour emergency services, diagnostic laboratory, 4 operating rooms under JCAHO standards, MRI and angiogram capabilities. Supports expansion of regenerative medicine field with state-of-the-art medical infrastructure.
  • Kimpton Grand Roatan Resort & Spa / Kao Kamasa SpacoreStrategic or Co-development PartnerCollaboration bringing regenerative IV therapies and aesthetic treatments to resort guests. GARM provides professionally trained medical team inside spa environment while Kimpton curates guest experience. Treatments include IV therapies, longevity drips, restorative drips, performance drips, stem cell & exosome drips, and regenerative aesthetic treatments.

Scale indicators7 records

Recent moves9 records

Expansion highlights6 records

Global Alliance for Regenerative Medicine competitors and assessment

Company assessment

Direct peers

  • BioXcellerator: Stem cell therapy clinic in Medellín, Colombia offering autologous and allogeneic treatments for orthopedic, autoimmune, and chronic conditions to international patients. Directly competes with GARM in the medical tourism regenerative medicine space.
  • Okyanos Center for Regenerative Medicine: Former Freeport, Bahamas-based regenerative medicine clinic using adult stem cell therapy under Bahamian regulatory framework. Direct geographic and regulatory peer to GARM's Bahamas location.
  • Regenexx: US network of interventional orthopedics clinics offering image-guided bone marrow concentrate injections and regenerative therapies. Comparable orthopedic regenerative medicine focus with broader US footprint.
  • Infusio: Frankfurt, Germany and US-based regenerative medicine clinic combining stem cell therapy, IV protocols, and longevity treatments. Comparable multi-modal longevity offering to GARM's Biological Reset and Klotho programs.
  • StemGenex: California-based stem cell therapy clinic offering autologous adipose-derived stem cell treatments for orthopedic and degenerative conditions. Closest US-domestic comparator with similar cell processing approach.
  • AgeRejuvenation: Miami-based regenerative medicine and hormone therapy clinic offering stem cell, PRP, and IV treatments to affluent domestic clientele. Comparable boutique regenerative medicine positioning in the US market.
  • Celltex Therapeutics: Autologous mesenchymal stem cell therapy provider operating in Cancun, Mexico, targeting US medical tourists with similar FDA-arbitrage model. Closest structural competitor to GARM in the regenerative medical tourism category.
  • Swiss Medica: Regenerative medicine clinic in Switzerland and Serbia offering stem cell therapy and anti-aging protocols to international patients. Comparable premium medical tourism positioning with longevity focus.

Broad incumbents

  • NuVasive (Globus Medical): Large medical device company focused on spine and orthopedic surgical solutions. Represents the conventional surgical alternative that GARM positions its regenerative treatments against.

Others

  • Klothea Bio: Alpha Klotho mRNA therapeutic developer currently running Phase 1b trial at GARM Clinic. Partner rather than competitor, but illustrative of biotech clients GARM could serve through its CRO platform.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Global Alliance for Regenerative Medicine social profiles

Digital presence

Global Alliance for Regenerative Medicine financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Global Alliance for Regenerative Medicine leadership team

Management profile

Number of profiles

Profiles9 records

Global Alliance for Regenerative Medicine funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Global Alliance for Regenerative Medicine M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Global Alliance for Regenerative Medicine

What does Global Alliance for Regenerative Medicine do?

GARM Clinic operates a regenerative medicine medical tourism platform delivering stem cell therapies (autologous, allogeneic, cultured, and MUSE-derived), gene therapies (Follistatin and VEGF plasmid), exosome therapies, PRP, and longevity protocols to affluent international patients. Treatments are physician-led, customized per patient after comprehensive diagnostics, and delivered at facilities in Roatán, Honduras and Paradise Island, Bahamas under regulatory frameworks that allow therapies not yet FDA-approved in the US.

Is Global Alliance for Regenerative Medicine a public or private company?

Global Alliance for Regenerative Medicine is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Global Alliance for Regenerative Medicine founded?

Global Alliance for Regenerative Medicine was founded in 2014. It employs 1 to 10 people.

Where is Global Alliance for Regenerative Medicine based?

Global Alliance for Regenerative Medicine is headquartered in Roatán, Honduras, in the Latin America region.

How does Global Alliance for Regenerative Medicine make money?

Four revenue lines are on record. Regenerative Medicine Treatments are the primary driver. The others are clinical Trial Hosting (CRO), longevity Programs and spa Partnership Treatments.

Who are Global Alliance for Regenerative Medicine's main competitors?

Direct peers on record are BioXcellerator, Okyanos Center for Regenerative Medicine, Regenexx, Infusio, StemGenex, AgeRejuvenation, Celltex Therapeutics and Swiss Medica. NuVasive (Globus Medical) is listed as a broad incumbent. Klothea Bio is listed as an others.

Does Global Alliance for Regenerative Medicine have an API?

No public API is recorded for Global Alliance for Regenerative Medicine.

What industry is Global Alliance for Regenerative Medicine in?

Global Alliance for Regenerative Medicine's product category is Regenerative Medicine. Its primary akta.pro industry code is HLAAABAA, Cell Therapy Developers (Autologous), with a secondary code of HLAAABAE, Stem Cell Therapies (MSC/iPSC/HSC-derived). Its NAICS code is 5417 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswireGARM CLINIC MAKES HISTORY WITH THE WORLD'S FIRST KLOTHO LONGEVITY RESIDENCYGARM Clinic held its inaugural Klotho Longevity Residency at Kimpton Grand Roatán Resort & Spa from June 4-7, 2026, bringing together three leading Klotho researchers with 22 attendees. The AKL003 protocol aims to restore declining Alpha Klotho levels, and GARM has scheduled a follow-up residency in September 2026.FinancialContent Business PageNymox's Nymozarfex(TM) Newly Available for Prostate Treatments for Medical Tourists in Collaboration with the Global Alliance of Regenerative Medicine on Roatan Island in the CaribbeanNymox Pharmaceutical Corporation has entered into a formal agreement with the Global Alliance of Regenerative Medicine (GARM) to offer its Nymozarfex(TM) drug treatment for prostate conditions at GARM's facility on Roatan Island in the Western Caribbean. The treatment will be provided by certified expert urologists and is positioned as an alternative for men seeking options beyond current drugs with side effects or surgical treatments. Nymox CEO Paul Averback framed the announcement as significant news for men needing better prostate care options, with the island location targeting medical tourists.Stock TitanNymox adds Roatan outlet for Nymozarfex prostate careNymox Pharmaceutical Corporation announced that its prostate treatment drug Nymozarfex(TM) is now available at the Global Alliance of Regenerative Medicine (GARM) facility on Roatan Island in the Caribbean for medical tourists. The partnership marks the drug's first public availability, with certified urologists providing the treatment at GARM's medical facility. Nymox CEO Paul Averback highlighted the treatment as a safer alternative to existing drugs and surgical options for prostate enlargement, citing fewer side effects and no anesthesia requirement.NewswireNymox's Nymozarfex(TM) Newly Available for Prostate Treatments for Medical Tourists in Collaboration with the Global Alliance of Regenerative Medicine on Roatan Island in the CaribbeanNymox Pharmaceutical announced an agreement to offer its Nymozarfex drug for prostate conditions on Roatan Island, Caribbean, through the Global Alliance of Regenerative Medicine. The drug is licensed and will be provided by certified urologists at GARM's facility. Nymox CEO Paul Averback said it is a safe alternative to current treatments.BioSpaceNymox’s Nymozarfex(TM) Newly Available for Prostate Treatments for Medical Tourists in Collaboration with the Global Alliance of Regenerative Medicine on Roatan Island in the CaribbeanNymox Pharmaceutical announced an agreement with GARM on Roatan Island to offer its Nymozarfex drug for prostate conditions. The drug, developed by Nymox, will be provided by certified urologists at GARM's facility, aiming to offer a non-anesthetic alternative to current treatments.EIN PresswireGARM Bahamas Ltd Opens at Hurricane Hole Marina Bringing Regenerative Medicine & Longevity Research to Paradise IslandGARM Bahamas Ltd opened a new clinic in Paradise Island at Hurricane Hole Medical Center, offering regenerative medicine and longevity treatments. The clinic provides proprietary gene therapies, stem cell treatments, and the BRAIN RESET protocol, with a team led by Dr. Robin Roberts and Dr. Glenn C. Terry.EIN PresswireGARM Clinic Showcases Regenerative & Longevity Therapies at Kimpton Grand Roatan Resort & Spa’s Food & Wine FestivalGARM Clinic sponsored the Food & Wine Festival 2026 at Kimpton Grand Roatán Resort & Spa, collaborating with Kao Kamasa Spa on a Wellness Zone offering skin rejuvenation, IV therapies, and NAD+ boosters. The clinic also hosted a Booster Bar and advanced facial treatments, with many services available ongoing through its spa partnership.GlobeNewswireKlothea Bio Announces the Launch of a Phase 1b Clinical Trial of AKL003, an Alpha Klotho mRNA Therapeutic, for the Extension of Human LifespanKlothea Bio launched a Phase 1b trial of AKL003, an alpha Klotho mRNA therapeutic, at GARM Clinic in Roatan, Honduras. The randomized, double-blind, placebo-controlled study enrolls 21 healthy adults, with two IV doses four weeks apart, to assess safety and serum alpha Klotho levels. The company expects an update on first participant dosing in coming weeks.